The role of NAGK cysteine deprotonation in nutrient stress and cancer progression
The role of NAGK cysteine deprotonation in nutrient stress and cancer progression
批准号:
10652823
负责人:
JOHN BLENIS
金额:
$8.48万
依托单位国家:
美国
项目类别:
财政年份:
2023
资助国家:
美国
项目状态:
未结题
起止时间:
2023-04-21 至 2025-03-31
关键词:
AttentionBindingCell CommunicationCellsCysteineDataDetectionDevelopmentDisease ProgressionEnsureEnvironmentEnvironmental Risk FactorEventFrequenciesGlobal ChangeGlutamineGrowthHexosaminesImmune EvasionIodoacetamideKnock-outLabelMalignant NeoplasmsMediatingMetabolicModificationN-Acetylglucosamine kinaseNeoplasm MetastasisNucleotidesNutrientNutrient DepletionOxidantsPathway interactionsPerfusionPhosphorylationPhosphotransferasesPolysaccharidesPredispositionProcessPropertyProteinsProteomeReactionRecyclingRegulationResearchResourcesRoleSignal TransductionSiteStimulusStressSulfhydryl CompoundsTherapeuticTherapeutic InterventionTissuesTumor PromotionWorkbiological adaptation to stresscancer cellcostdeprivationdeprotonationextracellularglycosylationglycosyltransferaseneoplastic cellnoveloxidationprogramsprotonationresilienceresponsesmall moleculesugarsugar nucleotidetherapeutic targettumortumor growthtumor microenvironmenttumor progressionuptake
中文摘要
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY/ ABSTRACT
Changes in cellular glycosylation support cancer growth and progression, but the biosynthetic pathways that
supply the required nucleotide-sugar precursors are resource intensive. The cell therefore utilizes salvage
pathways to recycle free sugars following glycan degradation or extracellular uptake, offsetting the need for their
de novo synthesis. Little is known about the extent to which cancer cells rely on sugar salvage pathways or how
these pathways are regulated. Recently, the salvage kinase responsible for phosphorylating N-
acetylglucosamine (GlcNAc) for reuse by the hexosamine biosynthetic pathway, N-acetyl-D-glucosamine kinase
(NAGK), was found to support tumor growth, providing early evidence that cancer cells may indeed rely heavily
on salvage. Preliminary data presented here show that NAGK is deprotonated at two cysteines in response to
nutrient limitation, a condition frequently encountered in the tumor microenvironment. Cysteine deprotonation
can alter protein activity and promote subsequent oxidation. This deprotonation is observed not just on NAGK,
but on proteins throughout the cell in what may be a previously unrecognized adaptation to stress. Cysteines,
especially in the deprotonated thiolate state, serves as ready sites of covalent inhibition by small molecule
electrophiles. Thus, the wide-spread increase in thiolates in response to nutrient limitation may represent a class
of proteins that are more responsive to covalent inhibition within stressed tumor cells than when in their
protonated thiol state in healthy, perfused tissue. The aims detailed in this proposal will first characterize the
effect of cysteine deprotonation on NAGK activity and its role in tumor growth and will then focus on identifying
the global changes in cysteine protonation status in response to nutrient limitation as well as the environmental
factors that promote this deprotonation. This work will characterize, both mechanistically and broadly, a novel
stress response that may promote tumor progression despite nutrient limitation but that may also render the
tumor more vulnerable to therapeutic intervention with small molecule electrophiles.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Propionate metabolism and cancer
-
批准号:10660197
-
项目类别:
-
资助金额:$63.44万
-
财政年份:2023
-
负责人:JOHN BLENIS
-
依托单位:
Molecular and Translational Oncology Research
-
批准号:9280411
-
项目类别:
-
资助金额:$27.23万
-
财政年份:2017
-
负责人:JOHN BLENIS
-
依托单位:
Molecular and Translational Oncology Research
-
批准号:10202497
-
项目类别:
-
资助金额:$28.53万
-
财政年份:2017
-
负责人:JOHN BLENIS
-
依托单位:
Molecular and biochemical basis of Lymphangioleiomyomatosis
-
批准号:8788716
-
项目类别:
-
资助金额:$49.51万
-
财政年份:2014
-
负责人:JOHN BLENIS
-
依托单位:
Molecular and biochemical basis of Lymphangioleiomyomatosis
-
批准号:8612928
-
项目类别:
-
资助金额:$49.81万
-
财政年份:2014
-
负责人:JOHN BLENIS
-
依托单位:
Molecular and biochemical basis of Lymphangioleiomyomatosis
-
批准号:9197682
-
项目类别:
-
资助金额:$50.27万
-
财政年份:2014
-
负责人:JOHN BLENIS
-
依托单位:
FASEB Conference on Protein Kinases
-
批准号:7331403
-
项目类别:
-
资助金额:$0.5万
-
财政年份:2007
-
负责人:JOHN BLENIS
-
依托单位:
FASEB Conference on Protein Kinases
-
批准号:7457859
-
项目类别:
-
资助金额:$0.5万
-
财政年份:2007
-
负责人:JOHN BLENIS
-
依托单位:
Development of a high content cell based screen for inhibitors of the mTOR signal
-
批准号:7680763
-
项目类别:
-
资助金额:$4.23万
-
财政年份:2007
-
负责人:JOHN BLENIS
-
依托单位:
Development of a high content cell based screen for inhibitors of the mTOR signal
-
批准号:7290648
-
项目类别:
-
资助金额:$21.15万
-
财政年份:2007
-
负责人:JOHN BLENIS
-
依托单位:
MOLECULAR AND GENETIC BASIS OF CELL PROLIF--GORDON CONF
-
批准号:2370780
-
项目类别:
-
资助金额:$0.4万
-
财政年份:1997
-
负责人:JOHN BLENIS
-
依托单位:
SIGNAL TRANSDUCTION TO P70 S6 KINASE 1
-
批准号:6386067
-
项目类别:
-
资助金额:$46.32万
-
财政年份:1995
-
负责人:JOHN BLENIS
-
依托单位:
Signal Transduction to p70 S6 Kinase 1
-
批准号:7463029
-
项目类别:
-
资助金额:$57.54万
-
财政年份:1995
-
负责人:JOHN BLENIS
-
依托单位:
SIGNAL TRANSDUCTION TO P70 S6 KINASE 1
-
批准号:6878608
-
项目类别:
-
资助金额:$56.64万
-
财政年份:1995
-
负责人:JOHN BLENIS
-
依托单位:
Signal Transduction to P70 S6 Kinase 1
-
批准号:8956533
-
项目类别:
-
资助金额:$22.5万
-
财政年份:1995
-
负责人:JOHN BLENIS
-
依托单位:
Signal Transduction to p70 S6 Kinase 1
-
批准号:7764664
-
项目类别:
-
资助金额:$64.57万
-
财政年份:1995
-
负责人:JOHN BLENIS
-
依托单位:
SIGNAL TRANSDUCTION TO PP70 S6K
-
批准号:2189912
-
项目类别:
-
资助金额:$16.85万
-
财政年份:1995
-
负责人:JOHN BLENIS
-
依托单位:
SIGNAL TRANSDUCTION TO PP70 S6K
-
批准号:2189911
-
项目类别:
-
资助金额:$17.28万
-
财政年份:1995
-
负责人:JOHN BLENIS
-
依托单位:
Signal Transduction to P70 S6 Kinase 1
-
批准号:8607186
-
项目类别:
-
资助金额:$39.3万
-
财政年份:1995
-
负责人:JOHN BLENIS
-
依托单位:
SIGNAL TRANSDUCTION TO P70 S6 KINASE 1
-
批准号:7037418
-
项目类别:
-
资助金额:$56.96万
-
财政年份:1995
-
负责人:JOHN BLENIS
-
依托单位:
国内基金
海外基金
登录
查看更多内容
帽结合蛋白(cap binding protein)调控乙烯信号转导的分子机制
-
批准号:32170319
-
项目类别:面上项目
-
资助金额:58.00万元
-
批准年份:2021
-
负责人:董春海
-
依托单位:
帽结合蛋白(cap binding protein)调控乙烯信号转导的分子机制
-
批准号:--
-
项目类别:--
-
资助金额:58万元
-
批准年份:2021
-
负责人:董春海
-
依托单位:
ID1 (Inhibitor of DNA binding 1) 在口蹄疫病毒感染中作用机制的研究
-
批准号:31672538
-
项目类别:面上项目
-
资助金额:62.0万元
-
批准年份:2016
-
负责人:孙跃峰
-
依托单位:
番茄EIN3-binding F-box蛋白2超表达诱导单性结实和果实成熟异常的机制研究
-
批准号:31372080
-
项目类别:面上项目
-
资助金额:80.0万元
-
批准年份:2013
-
负责人:杨迎伍
-
依托单位:
P53 binding protein 1 调控乳腺癌进展转移及化疗敏感性的机制研究
-
批准号:81172529
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2011
-
负责人:杨其峰
-
依托单位:
DBP(Vitamin D Binding Protein)在多发性硬化中的作用和相关机制的蛋白质组学研究
-
批准号:81070952
-
项目类别:面上项目
-
资助金额:35.0万元
-
批准年份:2010
-
负责人:刘师莲
-
依托单位:
研究EB1(End-Binding protein 1)的癌基因特性及作用机制
-
批准号:30672361
-
项目类别:面上项目
-
资助金额:24.0万元
-
批准年份:2006
-
负责人:徐宁志
-
依托单位: